Muutke küpsiste eelistusi

E-raamat: Behavioral Impact of Cannabinoids

Edited by , Edited by , Edited by
  • Formaat - EPUB+DRM
  • Hind: 221,68 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

Despite millennia of proximity to, and consumption of products from, the Cannabis plant, we have an incomplete understanding of its behavioural impact. This volume presents current research summaries in three sections, focussing on contextualisation of the work at molecular and cellular levels, and behavioural paradigms for investigating Cannabis and cannabinoid preparations in non-human animals and humans. The contributors are leaders in their respective fields and internationally recognisable.

The book contents are unique in the progression that it encompasses the molecular understanding of cannabinoids through animal models of behaviour into humans. It reflects a resurgence in attempts to understand the potential therapeutic benefits of Cannabis and cannabinoid preparations. This is evidenced by the increasing number of countries/states where Cannabis-based products for medicinal use have been approved, as well as some notable locations where non-medicinal consumption of Cannabis preparations has been legalised.

Preface.- Canonical Cannabinoid Receptors.- The pharmacological profile
of plant-derived cannabinoids in vitro.- Chemical Probes for Exploiting the
Endocannabinoid System.- Genetic Tools in Rodents to Study Cannabinoid
Functions.- Pharmacotherapy for Cannabis Use Disorder: Preclinical and
Clinical Models.- Delta-9-tetrahydrocannabinol and Cannabidiol for Pain:
Preclinical and Clinical Models.- Neurodegeneration and ageing.-
Cannabinoid-based pharmacology for the management of drug relapse.- The role
of cannabinoids and the endocannabinoid system in the treatment and
regulation of nausea and vomiting.- The use of cannabis-based medicine in
selected neurological disorders.